DOIC|CAS 1292821-06-7|cationic lipid for LNP|DC Chemicals

Cas No.:	1292821-06-7
Chemical Name:	DOIC
SMILES:	CCCCCCCC/C=C\CCCCCCCC(C1=[N+](C=CN1CCO)CCOC(CCCCCCC/C=C\CCCCCCCC)=O)=O.[Cl-]
Formula:	C₄₃H₇₇ClN₂O₄
M.Wt:	721.54
Purity:	>95%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Publication:	[1]. WESSELHOEFT A, et, al. Circular rna compositions and methods. WO2021236855A1.

Description:	DOIC is a cationic lipid that can be used for RNA vaccines.
References:	[1]. WESSELHOEFT A, et, al. Circular rna compositions and methods. WO2021236855A1.

Cat. No.	Product name	Field of application
DC71699	DOIC	DOIC is a cationic lipid that can be used for RNA vaccines.
DC70010	98N12-5	98N12-5 is an ionizable cationic lipid. It has been used in combination with other lipids in the generation of lipid nanoparticles (LNPs). LNPs containing 98N12-5 and encapsulating proprotein convertase subtilisin kexin type 9 (PCSK9) siRNA selectively accumulate in the liver and reduce total serum cholesterol levels in mice and rats and serum LDL levels in cynomolgus monkeys.
DC49932	FTT5	FTT5 is a lipid-like compound for efficient delivery of long mRNAs in vivo.
DC49889	503O13	503O13 is a next-generation, biodegradable lipid nanoparticle (LNP) engineered for highly efficient and targeted siRNA delivery. Designed through rational structure-activity criteria—including optimal tail length (O13), tertiary amines, and a surface pKa ≥5.5—this single-component LNP achieves unparalleled gene silencing with an ultra-low EC50 of 0.01 mg/kg in preclinical models.503O13 outperforms non-degradable counterparts (e.g., C12-200) with improved toxicity profiles—no hepatic necrosis or pancreatic inflammation—while maintaining rapid blood clearance (t1/2: 6 min) and organ-specific accumulation (liver/spleen).
DC47162	10-Nitrooleic acid	10-Nitrooleic acid (CXA-10), a nitro fatty acid, has potential effects in disease states in which oxidative stress, inflammation, fibrosis, and/or direct tissue toxicity play significant roles.